CLINICAL_TRIALS
trial_result
· 2019-06-14
Clinical Trial Update: everlinQ Endovascular Access System Enhancements (EASE) Study [NA]
Summary
The EASE study evaluating the everlinQ Endovascular Access System for chronic kidney disease has completed, with results posted on 2019-06-14.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: C. R. Bard | Conditions: Chronic Kidney Diseases | NA | Status: COMPLETED | Results posted: 2019-06-14